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T
he ﬁndings of the FANTOM3/
Genome Network project have
redeﬁned the landscape of the
mammalian transcriptome by
introducing an extensive collection of
novel cDNAs and millions of sequenced
tags corresponding to 59- and 39-ends
of mRNAs. This issue of PLoS Genetics
includes a special collection of articles
that explore the transcriptome
complexity being revealed by work on
the FANTOM3 dataset. Besides
revealing staggering complexity,
analysis of this collection is providing
an increasing number of novel mRNA
classes, expressed pseudogenes, and
bona ﬁde noncoding variants of
protein-coding genes. In addition, new
types of regulatory logic have emerged,
including sense–antisense mechanisms
of RNA regulation. This high-
resolution cDNA collection and its
analysis represent an important world
resource for discovery, and
demonstrate the value of large-scale
transcriptome approaches towards
understanding genome function.
The Era of Transcriptome
Technology: From RNA to
Function
After the completion of several
genome sequences [1,2] the scientiﬁc
community has been pondering what
type of technologies are necessary for
understanding the underlying biology
of genomes. Two classes of novel
technologies, one based on the
hybridization of nucleic acids and the
other on sequencing products from
mRNA libraries, are already affecting
the way we understand biological
systems. Hybridization-based methods,
such as genome tiling arrays [3–5], have
some speciﬁc advantages: in a single
experiment they can give a draft
description of the transcriptome, or of
genome elements selected by
chromatin immunoprecipitation
(ChIP) [6]. Although a general picture
of the transcriptome can be produced
quickly, important details such as
transcriptional start sites (TSSs) cannot
be accurately identiﬁed at single-base
resolution, nor can such methods
determine the exact exon connections
and strand orientation, resulting in
incomplete sequence information.
Considering that 11% of short exons
are not represented in Affymetrix tiling
arrays, the overall rate of false negative
and false positive exon detections is
20% and 5%, respectively (N. Maeda, S.
Kondo, D. Sasaki, and Y. Hayashizaki,
unpublished data). Despite these
limitations, tiling arrays provide an
important picture of the genome
output, for example, that 41.5% of
mRNA is restricted to nuclei, that there
are 10-fold more transcribed sequences
than there are annotated genes, and
that 44% of the RNA sequences are
never polyadenylated [3] and thus are
missing from cDNA collections.
Methods based on full-length cDNA
sequencing [7,8] are more intensive,
but provide a picture at a higher
resolution, including full sequence and
exon–exon connectivity data [9–12].
Because large-scale full-length cDNA
sequencing is expensive, novel mRNA
tag technologies that are based on
deriving sequence tags from full-length
cDNAs have been developed (by the
RIKEN group and others [13]). Three
new technologies speed up the process
of analysis: cap analysis of gene
expression (CAGE) [14], gene signature
cloning [11], and gene identiﬁcation of
signature [15]. The strategy of
sequencing the 59- and/or 39-ends of
transcripts enables increased
throughput and brings transcriptome
analysis to a new level. These
technologies have been fully exploited
in the FANTOM (Functional
Annotation of the Mouse) and Genome
Network (GN) Projects (see Box 1).
This special issue of PLoS Genetics is
focused on transcriptome analysis done
by GN and FANTOM3, carrying the
torch from two recently published
studies [11,12]. These studies force a
paradigm shift in the understanding of
the transcriptome. First, the studies
ﬁnd that 63% of the genome is
transcribed from at least one strand (in
contrast to the earlier belief that only
2% of the genome is transcribed into
protein-coding mRNAs). Second, an
unexpected amount of variation was
found in alternative splice forms (65%
of all transcriptional units [TUs]
contain alternatively splicing variants),
TSSs (which identify promoters), and
polyadenylation sites. The number of
TUs is somewhat reduced by the
occurrence of gene fusion (exon
sharing between neighboring genes),
but the ﬁnal number of TUs is still large
(.43,000), because of novel mRNAs.
Thus, the complex landscape of the
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ever before, and we are left with the
daunting task of annotating its
function and its usage in speciﬁc cells.
Expanding the Bright Matter of
the Transcriptome: More
Proteins!
Pulling together FANTOM3 and
public datasets, no more than 2,200
completely novel proteins were
identiﬁed, even when analyzing more
than 158,000 cDNAs. More striking is
the number of protein varieties
discovered: combining all the splice
variants gives at least 78,000 different
mammalian proteins generated from
approximately 20,000 protein-coding
TUs [11]. Alignment of cDNA to the
genome revealed splicing variations of
three, six, or nine nucleotides [16] and
identiﬁed novel splicing sites and
splicing mechanisms. The work of van
Nimwegen and colleagues improved
the alignment of cDNA on the genome
by developing the SPA algorithm,
which allows a much ﬁner alignment
of cDNA to the genome. This advance
allows us to better align the sequences,
identify the 59- and 39-end mapping
positions, and reduce the splicing
boundary errors, thus improving the
study of alternative splicing [17].
Based on the SPA algorithm, Chern et
al. further analyzed the functionality
of common small-length splice
variations at the splicing site [18].
They identiﬁed small splice variations
(mainly three nucleotides) that take
place in 43.7% of all acceptor sites
and 23.7% of all donor sites; these
variations derive from stochastic
binding of the spliceosome to the
neighboring splicing site. It is unclear
how these small-length splicing
polymorphisms affect protein
functions in various tissues, nor do we
know the extent of this phenomenon
in other organisms. We are used to
thinking that genes produce
compartment-speciﬁc proteins. But a
new analysis by Davis et al. shows that
alternative splicing causes the
produced proteins to have different
cellular compartment localizations in
more than 8% of TUs [19];
determining in greater detail the cell-
type speciﬁcity of such isoforms will
require additional work. Further
review of splicing in kinases and
phosphatases found that 69% of these
family members show alternative
splicing [20], including variants that
appear nonfunctional, but that with
more careful analysis are revealed to
be, respectively, decoy receptors and
peptides resembling proteolytic forms
still capable of binding extracellular
solutes. Although experimental
validation is needed, such forms would
be considered artifacts if we were not
analyzing an extensive and redundant
dataset.
An open question in the annotation
of the transcriptome is the minimal
length of a protein. Although this was
previously arbitrarily set at 100 amino
acids (aa), there is proof of the
existence of shorter proteins. Applying
the computer program CRITICA in a
novel way, Frith and colleagues
identiﬁed and experimentally veriﬁed a
missing fraction of the proteome,
which contains more than 3,000
candidate proteins (13% of the total
number of proteins) that are shorter
than 100 aa but longer than 50 aa, a
limit below which CRITICA does not
perform well, leaving the question
unanswered as to whether there are
even shorter unknown peptides [21].
Although many of these short proteins
are potentially truncated protein
variants, there are at least 1,240 that
are truly novel short proteins. A part of
all of these transcripts seems to be
composed of genuine transcripts that
seem to originate from within internal
exons of longer transcripts, as
described below (P. Carninci,
unpublished data).
Expanding the Dark Matter of
the Transcriptome: Noncoding
RNAs Require Our Attention
In the past, the total number of genes
was debated; early estimates ranged
from 28,000 to 120,000 genes, based on
expressed sequence tag clustering [22–
24]. Today, such a large discrepancy
can be at least partly explained by the
discovery of the large number of
noncoding genes and the variability of
TU ends, which, before the genome and
full-length cDNA sequences were made
available, appeared as distinct entities.
Additional knowledge of non-
polyadenylated RNA based on tiling
array technology can also contribute to
the explanation [3]. The novel ﬁnding
of 23,000 noncoding TUs and their
prominent biological role in the
regulation of gene expression has
dramatically changed the traditional
view of proteins as the only bioactive
molecules, and emphasizes the need to
modernize the central dogma.
To better distinguish between
protein-coding and noncoding
transcript, the FANTOM project has
helped develop various computational
tools to distinguish between non-
protein-coding RNA and regular
protein-coding mRNA. One of these
tools is addressed in the current issue
[25].
Two other papers further expand
previous discoveries regarding the
complexity of the transcriptome.
Furuno et al. [26] analyzed cDNAs that
may be constituted of fragments of
larger RNAs that are unclonable
because of their large size (such as the
large noncoding transcripts Air and
Xist), and that are potentially cloned as
59–39 truncated cDNA fragments
through internal priming. Their search
produced 2,700 large noncoding
candidate transcripts, of which a small
Box 1. About the FANTOM and
Genome Network Collaboration
FANTOM and GN (originally a Japanese
national project for establishing a system for
connecting genes with phenotypes and drug
targets/effects by using the same platform in
multiple biological systems) collaborated to
analyze novel transcriptome data consisting of
103,000 full-length cDNAs, more than 7 million
mouse and more than 5 million human CAGE
tags, and more than 1 million gene
identification of signature/gene signature
cloning ditags. This was a global collaboration
with many institutes (http://www.mext-life.jp/
genome/english/index.html). Within the
consortium, three meetings were organized
for the annotation of mouse full-length cDNA
sequences [9–12].
The strategy of handling the cDNA data is
described in Maeda et al. [45]. The data
resulting from the annotation meetings are
available at http://fantom.gsc.riken.jp, and
some integrated genomic data, annotated
cDNA, tags, and regulatory data have also
been published separately [46,47]. RIKEN
cDNA clones will be made available to
researchers from DNAFORM (http://www.
dnaform.jp/index_e.html). Future plans
include a large database, the Genome Network
Platform, which will be available at http://
genomenetwork.nig.ac.jp/public/
english_page.html, led by Gojobori’s group at
the DNA Data Bank of Japan (http://www.ddbj.
nig.ac.jp).
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(66 RNAs) were experimentally veriﬁed
and found to be true noncoding large
RNAs with potential regulatory
functions, like Ube3a and Kcnq1, which
were identiﬁed in this dataset. As a new
world of non-polyadenylated RNA was
recently identiﬁed and found to
compose at least half of the unknown
transcriptome [3], the number of true
noncoding RNAs with regulatory
functions found so far promises to be
only the tip of the iceberg.
The biological community has
considered pseudogenes to be a fossil
testimony of old genes once
transcribed or reintegrated into the
genome, being silent or phenotypically
irrelevant [27–30]. A ﬁrst indication
that this view might be incorrect was
the discovery a few years back that
pseudogenes can be expressed and
regulated through RNA–RNA
interaction [31]. In this issue, Frith and
colleagues [32] have extended the
analysis of noncoding transcript
expression and have identiﬁed 10,000
full-length cDNAs derived from
expressed pseudogenes—constituting
approximately 10% of the known
transcriptome—half of which are
promoted by retrotransposons, or
otherwise characterized promoters,
and are likely to participate in various
regulatory mechanisms. These data
suggest that we will need to continue to
remain open-minded about the
function of expressed pseudogenes as
‘‘potogenes’’ (potential genes) [33] and
ncRNAs.
Biological Significance of
Sense–Antisense
Antisense regulation of transcription
is one of the many roles of RNA [11]
and is one way a network of RNA
molecules affects the entire organism’s
phenotype. Short double-stranded
RNA has been found to form
regulatory chains at the genome,
nucleoprotein, transcriptional, post-
transcriptional, and translational level
(for review see [34]). The extensive
analysis of FANTOM3/GN showed that
more than 36,000 sense–antisense (S/
AS) pairs were encoded in the mouse
transcriptome. These pairs seem to
cover a large fraction of genes (72% of
the total number of transcripts),
including several important genes
responsible for human genetic diseases
and regulation of important cell
functions such as cell cycle arrest and
apoptosis [12]. Such prevalence of S/AS
is conﬁrmed with large-scale
expression SAGE analysis, suggesting
that more than 50% of the genes show
S/AS transcription [35].
Interestingly, CAGE data showed
that there is a preference for
transcripts that map head-to-head in
the genome, and in particular in the
case of nuclear genes [12], suggesting a
possible mechanism for transcriptional
interference. In this issue, Seno and
colleagues present an algorithm they
developed to search for the expression
of CAGE tags in the genome by looking
for regional bias in regions that show
signiﬁcant co-regulation of
transcription, including S/AS pairs [36].
By pooling together groups of CAGE
libraries for similar groups of tissues
(e.g., liver, lung, and macrophages,
regardless of their condition), they
identiﬁed S/AS transcription to be
particularly overrepresented in certain
loci, which strongly supports the
hypothesis that transcriptional
interference is a mechanism of
transcriptional regulation. The next
step regarding these data is to
determine whether there is a
correlation of cellular localization
among co-expressed genes (nuclear
versus cytoplasmic) and whether they
are co-expressed in the same cells and
from the same chromosome, in order
to distinguish between a number of
potential functional mechanisms.
The observation that S/AS pairs are
frequently clustered in complex
genomic regions was made possible by
using more than 158,000 cDNAs [11]
(Figure 1). Engstro ¨m et al. made a
comprehensive catalog of complex loci,
and have deﬁne the concept of ‘‘chain’’
for loci including at least three
independent transcripts in S/AS
relationship to each other or sharing a
bidirectional promoter [37]. The
rationale for such grouping is that such
loci will be subject to common
epigenetic relationships. They found
that there are approximately 1,000
mouse–human conserved chains (7-fold
more than known before) and that
these include genes that are
overrepresented in cancer, clearly
revealing the need for further attention
to expression dynamics in gene chains.
Variability within Transcripts
Highlights Complex
Transcriptional Regulation
Mechanisms
At a ﬁrst glance, the FANTOM tags
dataset has deﬁned TSSs and
transcriptional termination sites (TTSs)
that exceed the number of TUs, with an
average of ﬁve different TSSs and TTSs
per TU (see Figure 2). Taken together,
more than 181,000 different transcripts
were identiﬁed for cDNAs, with proven
evidence of TSSs and TTSs [12]. In
particular, the collections of tags have
helped in the identiﬁcation of more
than 230,000 TSSs in mouse. CAGE tags
alone have identiﬁed 160,000 TSSs in
mouse and 180,000 TSSs in human [38],
expanding the number of well-
annotated TSSs by several magnitudes
[39]. This dataset has identiﬁed a
functional dichotomy in mammalian
promoters between CpG islands and
TATA box promoters. Moreover, these
tags have identiﬁed further ‘‘dark
transcription matter’’ truly originating
from 39 untranslated regions and
coding exons. Analysis of expression
clusters and their core promoter
elements allows identiﬁcation of
regulatory elements and
reconstruction of transcriptional
networks and subnetworks after the
activation of macrophages with
lipopolysaccharides [40]. Bajic and
colleagues analyzed mouse and human
CAGE data and the local sequences
around promoters, distinguishing them
by their GC content at 59- and 39-ends
of TSSs. Most of the promoters were
indeed enriched in GC content, but
there were also groups that were AT-
rich in the same regions. The density of
transcription factor binding sites and
genes classiﬁed using Gene Ontology
terms [41] highlights the basic
differences that underlie
transcriptional control of different
gene categories, in agreement with our
unpublished results. Expanded analysis
of larger versions of such datasets will
hopefully help not only to identify
promoters, but also to predict their
possible promoter activity, based on
transcription factor binding site
mapping and usage.
Taking advantage of CAGE’s high
resolution, Taylor and colleagues
analyzed the evolution of core
promoter elements [42]. Of particular
interest is the fact that CAGE tags
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are under positive evolutionary
selection, in contrast to TATA box
promoters, which are evolving more
slowly because of spacing constraints.
As CpG promoters, TSSs are modular
and driven by pyrimidine/purine
dinucleotides [38]), conferring greater
transcription plasticity and thus
accelerating evolution, because
dramatic biological changes derive not
only from protein mutation but also
from differential expression levels. It
would be interesting to apply CAGE
technology to more evolutionarily
distant vertebrates and invertebrates
and further develop this concept of
evolutionary rates as it relates to
speciation.
What Developments Lie Ahead?
Tiling arrays and sequencing-based
technologies have provided great
insights—identifying several key roles
of the RNA and transcription itself, and
basic regulatory mechanisms. We have
so far uncovered only a portion of the
transcriptional complexity that exists,
and when considering variation in
tissues, cell development, and cell
stages, we have barely scraped the
surface of the unknown. For future
studies, further technological
development is needed, such as the
recent application of tagging
DOI: 10.1371/journal.pgen.0020063.g001
Figure 1. The Imprinted Gnas Locus Reveals the Complexity of the Transcriptome
There at least 50 different transcripts that overlap into about ten interconnected TUs. The upper panel shows the CAGE tags (TSSs). Pink and green
denote the two different transcript orientations on the genome. The size of the arrow corresponds to the number of overlapping CAGE tags. The middle
panel shows the regions of the genome that are utilized as exons, and the structure of known transcripts, with their annotation. The bottom two panels
show novel transcript boundaries, identified with gene signature cloning and gene identification of signature (GSC/GIS) and 59–39 paired expressed
sequence tags (ESTs).
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sequencing analysis [43] as a part of the
‘‘$1,000 genome project.’’ We need to
be able to screen for the function of
noncoding RNA, including the
signiﬁcance of cis and trans S/AS
interactions in living cells, and their
roles in transcriptional interference, as
epigenetic effectors, and yet unknown
roles. Integration of these RNA
functions and RNA variability into
formally described gene models and
their relation with phenotypes will then
be required.
These datasets are complementary to
and an integral part of the ENCODE
project [44], a project devoted to the
annotation of the entire human
genome’s regulatory elements.
Integration of these two large-scale
datasets will form the framework for
future post-genomic studies. Hopefully,
the future will see more comprehensive
transcriptome projects ﬂanking the
basic genome sequencing projects,
greatly enriching our knowledge and
understanding of biology. &
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